INOVIQ Management
Management criteria checks 2/4
INOVIQ's CEO is Leearne Hinch, appointed in Nov 2016, has a tenure of 8.08 years. total yearly compensation is A$609.31K, comprised of 68% salary and 32% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth A$142.66K. The average tenure of the management team and the board of directors is 3.3 years and 5 years respectively.
Key information
Leearne Hinch
Chief executive officer
AU$609.3k
Total compensation
| CEO salary percentage | 68.0% |
| CEO tenure | 8.1yrs |
| CEO ownership | 0.2% |
| Management average tenure | 3.3yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
We Think INOVIQ (ASX:IIQ) Can Afford To Drive Business Growth
Apr 22
A Look At The Intrinsic Value Of INOVIQ Ltd (ASX:IIQ)
Mar 01We Think Shareholders May Want To Consider A Review Of INOVIQ Ltd's (ASX:IIQ) CEO Compensation Package
Nov 22Companies Like INOVIQ (ASX:IIQ) Are In A Position To Invest In Growth
Jun 21Companies Like INOVIQ (ASX:IIQ) Are In A Position To Invest In Growth
Feb 16INOVIQ (ASX:IIQ) Is In A Good Position To Deliver On Growth Plans
Sep 28We're Hopeful That INOVIQ (ASX:IIQ) Will Use Its Cash Wisely
Jun 08We're Keeping An Eye On INOVIQ's (ASX:IIQ) Cash Burn Rate
Jan 28Are Insiders Selling BARD1 Life Sciences Limited (ASX:BD1) Stock?
Mar 02Don't Ignore The Fact That This Insider Just Sold Some Shares In BARD1 Life Sciences Limited (ASX:BD1)
Mar 02BARD1 Life Sciences (ASX:BD1) Is In A Good Position To Deliver On Growth Plans
Dec 28CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$609k | AU$414k | -AU$7m |
| Mar 31 2024 | n/a | n/a | -AU$7m |
| Dec 31 2023 | n/a | n/a | -AU$7m |
| Sep 30 2023 | n/a | n/a | -AU$8m |
| Jun 30 2023 | AU$558k | AU$396k | -AU$9m |
| Mar 31 2023 | n/a | n/a | -AU$15m |
| Dec 31 2022 | n/a | n/a | -AU$21m |
| Sep 30 2022 | n/a | n/a | -AU$20m |
| Jun 30 2022 | AU$485k | AU$376k | -AU$18m |
| Mar 31 2022 | n/a | n/a | -AU$14m |
| Dec 31 2021 | n/a | n/a | -AU$11m |
| Sep 30 2021 | n/a | n/a | -AU$11m |
| Jun 30 2021 | AU$867k | AU$330k | -AU$11m |
| Mar 31 2021 | n/a | n/a | -AU$8m |
| Dec 31 2020 | n/a | n/a | -AU$5m |
| Sep 30 2020 | n/a | n/a | -AU$4m |
| Jun 30 2020 | AU$712k | AU$330k | -AU$3m |
| Mar 31 2020 | n/a | n/a | -AU$3m |
| Dec 31 2019 | n/a | n/a | -AU$2m |
| Sep 30 2019 | n/a | n/a | -AU$2m |
| Jun 30 2019 | AU$442k | AU$361k | -AU$2m |
| Mar 31 2019 | n/a | n/a | -AU$2m |
| Dec 31 2018 | n/a | n/a | -AU$2m |
| Sep 30 2018 | n/a | n/a | -AU$2m |
| Jun 30 2018 | AU$403k | AU$359k | -AU$2m |
Compensation vs Market: Leearne's total compensation ($USD379.40K) is above average for companies of similar size in the Australian market ($USD290.31K).
Compensation vs Earnings: Leearne's compensation has increased whilst the company is unprofitable.
CEO
Leearne Hinch
8.1yrs
Tenure
AU$609,311
Compensation
Dr. Leearne Maree Hinch, BSc., B.V.M.S., M.R.C.V.S., M.B.A. has been the Chief Executive Officer of INOVIQ Ltd (formerly known as BARD1 Life Sciences Limited) since November 7, 2016. Dr. Hinch is a biotech...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 8.1yrs | AU$609.31k | 0.25% A$ 144.0k | |
| CFO & Company Secretary | 2.1yrs | AU$322.87k | 0.036% A$ 21.0k | |
| Chief Scientific Officer | 3.3yrs | AU$350.25k | 0.054% A$ 31.5k |
3.3yrs
Average Tenure
Experienced Management: IIQ's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Non-Executive Director | 5.5yrs | AU$62.90k | 0.48% A$ 280.7k | |
| Non-Executive Chairman | 1.1yrs | AU$729.81k | 4.64% A$ 2.7m | |
| Independent Non-Executive Director | 4.4yrs | AU$74.93k | 0.21% A$ 124.6k | |
| Independent Non-Executive Director | 5.5yrs | AU$62.90k | 0.54% A$ 317.3k | |
| Member of Advisory Board | 7.4yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
5.0yrs
Average Tenure
Experienced Board: IIQ's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 15:07 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
INOVIQ Ltd is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Chris Kallos | MST Financial Services Pty Limited |